We stratified cell lines by MYC Target V1 signature enrichment (top and bottom 35%) from the Cancer Cell Line Encyclopedia [18] (Supporting Figure 3B) and compared the drug IC50s between two cell line groups (Figure 3D). This evidence concerns the gene MYC and cancer.